Top Markets
Coin of the day
Biotage AB (publ) Biotage AB (publ)

Biotage AB (publ)

BIOT
주식 순위 #8384
Biotage AB (publ), established in 1969 and based in Uppsala, Sweden,... Biotage AB (publ), established in 1969 and based in Uppsala, Sweden, specializes in providing advanced separation technologies essential for fields such as organic and analytical chemistry, biomolecule research, and industrial scale-up applications. The company offers a comprehensive range of products, including solutions for organic and peptide synthesis, flash chromatography, evaporation, and work-up procedures, along with specialized systems, accessories, and various cartridges (normal, reversed, and specialty phase). Biotage also supplies solutions for plasmid and protein purification, encompassing antibody and tagged protein purification, automation systems, custom packing services, and diverse PhyTip columns. Additionally, they provide extensive sample preparation solutions tailored for clinical, bioanalytical, forensic, toxicology, doping control, environmental, and food and agriculture sectors, complemented by necessary consumables. Their offerings further include metal scavengers, reagents, and essential spare parts. Biotage serves a broad client base, including pharmaceutical and biotechnical companies, contract research and manufacturing organizations, government agencies, academic institutions, and various clinical, forensic, and academic laboratories. With a significant global footprint, the company operates in 70 countries across the Americas, Europe, the Middle East, Africa, and Asia Pacific.
주가
$15.99
마지막 동기화: 2025-07-21
시가총액
$1.28B
변동 (1일)
8.12%
변동 (1년)
0.00%
국가
SE
거래 Biotage AB (publ) (BIOT)

카테고리

Biotage AB (publ) (BIOT)의 매출
Aug 2026 기준 매출 TTM: 0
Biotage AB (publ)의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Biotage AB (publ)의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
$11.03B -
US
$34.74B -
FR
- -
JP
$20.84B -
US
- -
CH